Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.
Sumiyoshi T, Iijima K, Fujiki S, Hirabayashi K, Matsumoto H, Kuroda S, Hayashi H, Nakagawa Y, Takahashi K, Okabe M, Kusano K, Owada S, Kondo Y, Tsujita K, Kubota Y, Tomita H, Anzai T, Shoda M, Watanabe M, Tokano T, Murohara T, Kaneshiro T, Kato T, Fukaya H, Maemura K, Umemoto T, Katou R, Saigawa T, Naito S, Ando K, Yano M, Nitta J, Miura T, Yamashita Y, Kario K, Igarashi M, Yoshida H, Tanaka T, Node K, Minamino T.
Sumiyoshi T, et al.
Circulation. 2026 Apr 28;153(17):1343-1346. doi: 10.1161/CIRCULATIONAHA.125.077634. Epub 2026 Apr 27.
Circulation. 2026.
PMID: 42044212
No abstract available.